Physician profile
Scott E Goldsmith
NPI 1619166261
$13,389.15
in general payments reported to CMS, 2019-2025
16 companies · $494 in 2025
The $494 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,553 · 2020: $1,814 · 2021: $774 · 2022: $568 · 2023: $1,271 · 2024: $915 · 2025: $494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,680.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,769.34 | 2019-2025 | Mako, Gamma, T2 |
| Ethicon US, LLC | $5,556.68 | 2019-2020 | |
| Medtronic USA, INC. | $655.33 | 2019 | |
| Mvp Orthopedics INC | $293.54 | 2020-2022 | |
| Alphatec Spine, INC | $277.12 | 2023 | Other - Miscellaneous |
| Coastal Medical Technologies LLC | $208.59 | 2025 | |
| Trice Medical, INC. | $200.00 | 2019 | |
| Smith+Nephew, INC. | $180.66 | 2021-2023 | Bone Anchors With Arthroscopic Delivery System |
| Janssen Scientific Affairs, LLC | $122.58 | 2023 | Tecvayli |
| Theragen, INC. | $32.41 | 2022-2023 | Kneehab Xp |
| Eagle Pharmaceuticals, INC. | $19.62 | 2023 | |
| Abbott Laboratories | $16.02 | 2019 | |
| Arthrex, INC. | $16.00 | 2020 | |
| Heron Therapeutics, INC. | $14.89 | 2024 | Zynrelef |
| Heraeus Medical, LLC. | $14.03 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $12.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Goldsmith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.